Glycogen synthase kinase-3: A promising therapeutic target for Fragile X Syndrome
Recent advances in understanding the pathophysiological mechanisms contributing to Fragile X Syndrome (FXS) have increased optimism that drug interventions can provide significant therapeutic benefits. FXS results from inadequate expression of functional fragile X mental retardation protein (FMRP)....
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2011-11-01
|
| Seri Bilgileri: | Frontiers in Molecular Neuroscience |
| Konular: | |
| Online Erişim: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2011.00035/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|